Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, which is the active ingredient in Eli Lily's Mounjaro and Zepbound, are considered GLP-1 drugs
Other Benefits of Semaglutide: Notable and long-lasting weight loss Suppression of appetite Blood sugar control Increased sensation of fullness Reduction in the size of the waist Improved cardiovascular well-being Positive effects on overall metabolic health Increased longevity in maintaining weight Possible decrease in risk factors linked to illnesses connected to obesity Who is a Candidate for Semaglutide Injections
So all those things have to be neutralized, have to be conjugated, have to get rid of it from your body
Always eat protein or fat with your carbs to preven those insulin spikes
SUs as the Standard of Care in the GCC Modern guidelines and consensuses available for diabetes management have expressed mixed opinions regarding SU use, and while they categorize relevance according to different SU drugs and the patients preexisting conditions, SUs in general, remained consistently popular throughout the decades, and have secured their place in the contemporary arsenal for the global fight against diabetes for the years to come